Plasma free fraction of [123I]-IBZM was determined using ultrafiltration (Centrifree, 30000 MW).62 (link) The plasma metabolite analysis of [123I]-IBZM was performed using Oasis WCX (Waters) solid phase extraction units and stepwise elution with water, 40% acetonitrile and acidified 95% methanol. The native compound was eluted in the water phase and the metabolites in the subsequent elution.
All participants had a structural MRI scan performed for co-registration. The HC were only scanned at baseline to reduce the radiation dose.
Note that the supplementary material contains the details of the SPECT and MRI acquisitions.